Patent Foramen Ovale and Stroke Risk: Incidental Finding or Causal Culprit?

ABSTRACT

Between 17 and 27% of the population has a patent foramen ovale (PFO) based on autopsy studies. Given these percentages, a PFO could be considered a variant of normal cardiac anatomy and not an anomaly. As this anatomy is so prevalent in the normal population, it is likely that there are other factors involved in patients who have a PFO and a stroke. This review will evaluate the existing literature on PFO and stroke to determine what constitutes an increased risk of embolic events in patients with PFO. Given the paucity of existing literature, it is clear from this review that there is a vital need for randomized clinical trials to answer important questions, including what constitutes high-risk anatomy and optimal treatment for patients for the prevention of recurrent stroke.

Patent foramen ovale - atrial septal aneurysm - paradoxical embolism - stroke

REFERENCES

• 1 Seib G. Incidence of a patent foramen ovale cordis in adult American white and American negroes.  J Anat. 1934;  55 511-525
• 2 Hagen P T, Scholz D G, Edwards W D. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts.  Mayo Clin Proc. 1984;  59 17-20
• 3 Schrader R. Indication and techniques of transcatheter closure of patent foramen ovale.  J Interv Cardiol. 2003;  16 543-551
• 4 Lethen H, Flachskampf F, Schneider R et al.. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack.  Am J Cardiol. 1997;  80 1066-1069
• 5 Ranoux D, Cohen A, Cabanes L et al.. Patent foramen ovale: is stroke due to paradoxical embolism?.  Stroke. 1993;  24 31-34
• 6 De Castro S, Cartoni D, Fiorelli M et al.. Morphological and functional characteristics of patent foramen ovale and their embolic implications.  Stroke. 2000;  31 2407-2413
• 7 Rice M J, McDonald R W, Reller M D. Fetal atrial septal aneurysm: a cause of fetal atrial arrhythmias.  J Am Coll Cardiol. 1988;  12 1292-1297
• 8 Karttunen V, Hiltunen L, Rasi V et al.. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.  Blood Coagul Fibrinolysis. 2003;  14 261-268
• 9 Leung D Y, Black I W, Cranney G B et al.. Selection of patients for transesophageal echocardiography after stroke and systemic embolic events. role of transthoracic echocardiography.  Stroke. 1995;  26 1820-1824
• 10 Hamann G F, Schatzer-Klotz D, Frohlig G et al.. Femoral injection of echo contrast medium may increase the sensitivity of testing for a patent foramen ovale.  Neurology. 1998;  50 1423-1428
• 11 Mas J L, Arquizan C, Lamy C et al.. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.  N Engl J Med. 2001;  345 1740-1746
• 12 Stone D A, Godard J, Corretti M C et al.. Patent foramen ovale: association between degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurological events.  Am Heart J. 1996;  131 158-161
• 13 Homma S, Sacco R L, Di Tullio M R, Sciacca R R, Mohr J P. PFO in Cryptogenic Stroke (PICSS) Investigators. Effect of medical treatment in stroke patients with patient foramen ovale: patent foramen ovale in cryptogenic stroke study.  Circulation. 2002;  105 2625-2631
• 14 Overell J R, Bone I, Lees K R. Interatrial septal abnormalities and stroke: a meta analysis of case-control studies.  Neurology. 2000;  55 1172-1179
• 15 Petty G, Bijoy K, Meissner I et al.. A population based study of the relationship between patent foramen ovale and cerebrovascular ischemic events.  Neurology. 2003;  60 A256
• 16 Homma S, Di Tullio M, Sacco R et al.. Surgical closure of patent foramen ovale in cryptogenic stroke patients.  Stroke. 1997;  28 2376-2381
• 17 Okura H, Inoue H, Tomon M, Nishiyama S, Yoshikawa T, Yoshida K. Transesophageal echocardiographic detection of cardiac sources of embolism in elderly patients with ischemic stroke.  Intern Med. 1999;  38 766-772
• 18 Mohr J P, Thompson J LP, Lazar B et al.. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.  N Engl J Med. 2001;  345 1444-1451
• 19 Albers G, Amarenco P, Easton J D et al.. Antithrombotic and thrombolytic therapy for ischemic stroke: the seventh ACCP conference on antithrombotic and thrombolytic therapy.  Chest. 2004;  126 483S-513S
• 20 Meier B, Lock J E. Contemporary management of patent foramen ovale.  Circulation. 2003;  107 5-9
• 21 Adams Jr H P. Patent foramen ovale: paradoxical embolism and paradoxical data.  Mayo Clin Proc. 2004;  79 15-20
• 22 Messe S R, Silverman I E, Kizer J R et al.. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm.  Neurology. 2004;  62 1042-1050